Calcium inhibitors in the management of hypertensive patients on cyclosporine;Interet des antagonistes calciques dans la prise en charge therapeutique des patients hypertendus traites par ciclosporine

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue 4, 1998, Pages 411-414

  Bagnis, C ^b   Deray, G ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; CYTOCHROME P450; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG OVERDOSE; DRUG TOLERABILITY; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; NEPHROTOXICITY; ORGAN TRANSPLANTATION; BLOOD PRESSURE; DRUG EFFECT; DRUG INTERACTION; REVIEW;

BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CYCLOSPORINE; DRUG INTERACTIONS; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS;

EID: 0032038151     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Murray BM, Paller MS, Ferris TE. Effects of cytosporine administration on renal hemodynamics in the conscious rat. Kidney Int 1985 ; 28 : 767-74.
2. Ciresi DL, Iloyd MA, Sandberg SM, Heublin DM, Edwards BS. The sodium retaining effect of cyclosporin. Kidney Int 1992 ; 41 : 1599-605.
3. Curtis JJ, Luke RG, Jones P, Diethelm AG. Hypertension in cyclosporine treated renal transplant recipients is sodium dependent. Am J Med 1988 ; 85 : 134-8.
4. Cofflan TM, Carr DR, Yarger WE, Klootman PE. Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporin nephrotoxicity. Transplantation 1987 ; 43 : 282-91.
5. Abassi ZA, Pieruzzi F, Nakhoul F, Keiser HR. Effects of cyclosporin A on the synthesis excretion and metabolism of endothelin in the rat. Hypertendion, 1996 ; 27 : 1140-8.
6. Sherrer U, Vissing S, Morgan BJ et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990 ; 323 : 693-9.
7. Perico N, Benignin A, Zoja C, Delaini F, Remuzzi G. Functionnal significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A. Am J Physiol 1986 ; 251 : 4-12.
8. Bartholomeusz B, Hardy KJ, Nelson AS, Phillips PA. Bosentan ameliorates cyclosporine A-induced hypertension in rats and primates. Hypertension 1996 ; 27 : 13241-5.
9. Hamilton DV, Carmichael DJS, Evans DB, Calne RY. Hypertension in renal transplant recipients on cyclosporine A and corticosteroids and azathioprine. Transplant Proc 1982 ; 14 : 597-600.
10. Hardesty RL, Griffith BP, Debski RF et al. Experience with cyclosporine in cardiac transplantation. Transplant Proc 1993 ; 15 (suppl 1) : 2553-8.
11. Starling RC, Cody RJ. Cardiac transplant hypertension. Am J Cardiol 1990 ; 65 : 106-11.
12. O Grady J, Forbes A, Rolles K, Calne RY, Williams R. An analysis of cyclosporine efficacy and toxicity after liver transplantation. Transplantation 1988 ; 45 : 575-9.
13. Benmasour A, Wending D. Ciclosporine et polyarthrite rhumatoïde. Rhumatologie 1994 ; 46 (7) : 171-9.
14. Deray G, Benhmida M, Le Hoang P et al. Renal function and blood pressure in patients receiveing longterm, low-dose cyclosporine therapy for idiopathic auto-immune uveitis. Ann Intern Med 1992 ; 117 : 578-83.
15. Sturrock NDC, Lang CC, Baylis PH, Stuthers AD. Sequential effects of cyclosporine therapy in blood pressure renal function and neurohormones. Kidney Int 1994 ; 45 : 1203-10.
16. Noordjij TC, Leunissen KM, Van Hoof JP. Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use. Transplantation 1991 ; 52 : 64-7.
17. Deray G, Baumelou B, Le Hoang P et al. Enhancement of cyclosporin nephrotoxicity by diuretic therapy. Clin Nephrol 1989 ; 32 : 47-52.
18. Pedersen EB, Madsen JK, Sorensen SS, Zachariae H. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies. Kidney Int 1966 ; 49 (suppl 55) : S94-S96.
19. Ambrosi P, Bertucci B, Bertault-Péres P, Métras D. Felodipine in hypertensive heart transplant recipients. J Heart Lung Transplant 1996 ; 15 : 540-1.
20. Burke M, Arnold P, Gordon J et al. Protective effect of intrarenal calcium membrane blockers before or after renal ischemia. J Clin Invest 1984 ; 74 : 1830-41.
21. Dieperink H, Hansen HV, Ken M, Leyssac PP, Starkun TH, Kem PE. Antagonist capacity of felodipine on cyclosporin A nephrotoxicity in the rat. Nephrol Dial Transplant 1992 ; 7 : 1124-9.
22. Lodefoged SD, Pedersen E, Hammer M, Rasmussen KC, Hansen FM, Andersen CB. Influence of diltiazem on renal function and rejection in renal allograft recipients receiving triple-drug immunosuppression : a randomized, double-blind, placebo controlled study. Nephrol Dial Transplant 1994 ; 9 : 543-7.
23. Sorensen SS, Skoubou H, Eiskjaer H et al. Effect of felodipine on renal haemodynamics and tubular sodium handling in cyclosporin treated renal transplant recipients. Nephrol Dial Transplant 1992 ; 7 : 69-78.
24. Pochet JM, Pirson Y. Cyclosporin-diltiazem interaction (letter). Lancet 1986 ; 1 : 979.
25. Bourbigot B, Guiserix J, Airiau J, Bressollette L, Morin JF, Cledes J. Nicardipine increases cyclosporine blood levels (letter). Lancet 1986 ; 1 : 1447.
26. Toupance O, Lavand S, Canivet E, Bernard C, Holton J, Chanard J. Antihypertensive effect of amlodipine and lack of effect with cyclosporin metabolism in renal transplant recipients. Hypertension 1994 ; 24 : 297-300.
27. Pesavento T, Jones P, Julian B, Curtis J. Amlodipine increases cyclosporine levels in hypertensive renal transplant patients. results of a prospective study. J Am Soc Nephrol 1996 ; 7 : 831-5.
28. Van Der Schaaf M, Hene RJ, Floor M, Blankestfin PJ, Koomans HA. Hypertension after renal transplantation calcium channel or converting enzyme blockade. Hypertension 1995 ; 25 : 77-81.
29. Sennesael J, Lamote J, Violet I, Tasse S, Verbeelen D. Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporin treated renal allograft recipients. Am J Kidney Dis 1996 ; 27 : 701-8.
30. Madsen J, Korneru Ph, Sorensen S, Zachariae H, Pedersen E. Ciclosporine nephrotoxicity can be counteracted by a calcium antagonist (felodipine) in acute and short-term studies (abstract). J Am Soc Nephrol 1995 ; 6 : 1102.